On the upside
Acadia Pharmaceuticals (Nasdaq: ACAD) announced positive results from a Phase III clinical trial of its Parkinson's disease psychosis treatment pimavanserin.
Goldman Sachs initiated coverage of Crocs (Nasdaq: CROX) with a Buy rating.
On the downside
Neptune Technologies (Nasdaq: NEPT) resumed trading after an explosion on November 8 completely destroyed production at its Sherbrooke, Quebec facilities and halted trading on the stock.
Thor Industries (NYSE: THO) reported higher first quarter earnings but the results fell short of analyst expectations.
Shares of McMoRan Exploration (NYSE: MMR) continued falling after announcing yesterday that drilling tests were taking more time than expected.
In the broad market, declining issues were on par with advancers on the NYSE while advancers edged out decliners by a margin of 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks held steady at 809.